๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study

โœ Scribed by Lo, Wai-Kei; Ho, Yiu-Wing; Li, Chun-Sang; Wong, Kin-Shing; Chan, Tak-Mao; Yu, Alex Wai-Yin; Ng, Flora So-King; Cheng, Ignatius Kum-Po


Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
285 KB
Volume
64
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background:

There has been a lack of randomized control study on the effect of kt/v on patient outcome. this interventional study was designed to examine the effect of kt/v on continuous ambulatory peritoneal dialysis (capd) patients' clinical outcome and nutritional status in a randomized prospective manner.

Method:

A total of 320 new capd patients with baseline renal kt/v <1.0 were recruited from six centers in hong kong and were randomized into three kt/v targets: group a, 1.5 to 1.7; group b, 1.7 to 2.0; and group c,>2.0. kt/v and nutritional status were assessed every 6 months and dialysis prescription adjusted accordingly. nutritional assessment included serum albumin and composite nutritional index (cni). patients were allowed to withdraw at the discretion of their physicians or themselves.

Results:

Total kt/v were significantly different between groups (p = 0.000) and the difference was contributed by peritoneal kt/v only. the overall 2-year patient survival was 84.9%. there was no statistical difference in patient survival among the three groups (2-year survival in group a, 87.3%; group b, 86.1%; and group c, 81.5%). however, there were more patients withdrawn by physicians in group a (group a, 16; group b, 7; and group c, 6; p = 0.023). total kt/v or kt did not significantly affect survival after adjustment to age and diabetes. there was no difference in serum albumin, cni scores, and hospitalization rate, but there were more patients in group a requiring erythropoietin (epo) treatment after 1 year.

Conclusion:

Patients with total kt/v maintained below 1.7 had significantly more clinical problems and severe anemia but there was no difference in outcome demonstrated for patients with kt/v maintained above 2.0 and between 1.7 and 2.0. we recommended that the minimal target of total kt/v should be above 1.7.


๐Ÿ“œ SIMILAR VOLUMES


Impact of nutrition on outcome: A prospe
โœ Paula Ravasco; Isabel Monteiro-Grillo; Pedro Marques Vidal; Maria Ermelinda Cami ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 545 KB

## Background: We aimed to determine the effect of dietary counseling or oral supplements on outcome for patients with cancer, specifically, nutritional outcome, morbidity, and quality of life (qol), during and 3 months after radiotherapy. ## Methods: Seventy-five patients with head and neck canc

Palliative nutritional intervention in a
โœ Kent Lundholm; Peter Daneryd; Ingvar Bosaeus; Ulla Kรถrner; Elisabet Lindholm ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 253 KB

## Abstract ## BACKGROUND The role of nutrition in the palliative treatment of patients with malignancyโ€related cachexia is unclear. The goal of the current study was to determine whether specialized, nutritionโ€focused patient care could improve integrated wholeโ€body metabolism and functional outc

The effect of metrizamide on the electro
โœ Dr. Allan H. Ropper; Keith H. Chiappa; Robert R. Young ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 403 KB ๐Ÿ‘ 2 views

## Abstract A prospective study was made of changes in the electroencephalogram after the use of metrizamide for myelography and posterior fossa cisternography in 61 patients (62 studies). The EEG changed in 21 patients (34%); 3 of these had had previously abnormal records, and the abnormalities we

The prophylactic effect of aprotinin on
โœ L Garcia-Huete; P Domenech; A Sabate; F Martinez-Brotons; E Jaurrieta; J Figuera ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB

Fibrinolysis has been recognized as an important cause of intraoperative bleeding during orthotopic liver transplantation (OLT). Several investigators have used prophylactic administration of aprotinin in patients to inhibit fibrinolysis and to decrease transfusion requirements, morbidity, and morta